Rapid progress in the ability to manipulate the human body at the cellular level has opened up a huge field of opportunity for businesses with cutting edge knowledge and skill.
Herndon Biotechnology fund has a growing portfolio of cutting edge Biotech companies who are at the forefront of the new frontier of health and life span improvement. This helps all of humanity. It also happens to be an amazing investment opportunity!
Herndon is actively looking to partner with companies and innovators seeking to solve medical problems through biological intervention. We firmly believe that this approach will supplant the current pharmacological regime, and Herndon is determined to be a part of this revolution.